Shahin Khadem Azarian

Preclinical and pharmacotoxicology evaluation of α-l-guluronic acid (G2013) as a non-steroidal anti-inflammatory drug with immunomodulatory property

M. Abdollahi, R. Sedaghat, Farzaneh Tofighi Zavareh, 2017, Immunopharmacology and immunotoxicology.

Effects of guluronic acid, as a new NSAID with immunomodulatory properties on IL-17, RORγt, IL-4 and GATA-3 gene expression in rheumatoid arthritis patients

G. Azizi, F. Jafarnezhad‐Ansariha, A. Mirshafiey, 2019, Immunopharmacology and immunotoxicology.

A randomized clinical trial for the assessment of the efficacy and safety of guluronic acid (G2013) in patients with rheumatoid arthritis

S. Mostafaei, M. Mahmoudi, A. Jamshidi, 2019, Immunopharmacology and immunotoxicology.

Monogenic Auto-inflammatory Syndromes: A Review of the Literature.

G. Azizi, A. Mirshafiey, S. Nazeri, 2016, Iranian journal of allergy, asthma, and immunology.

The safety and efficacy of Guluronic acid (G2013) in ankylosing spondylitis: A randomized controlled parallel clinical trial

M. Hosseini, S. Mostafaei, M. Mahmoudi, 2019, Pharmacological reports : PR.